Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas

CORC > 合肥物质科学研究院 > 中国科学院合肥物质科学研究院 > 医学 > 专题未命名

	Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas
	Qi S(亓爽)
刊名	J. Med. Chem.
	2021-10-19
语种	英语
WOS记录号	WOS:000713412900016
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/125922]
专题	医学_专题未命名
作者单位	CHMFL-HCMTC Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui, 230031, PR China
推荐引用方式 GB/T 7714	Qi S. Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas[J]. J. Med. Chem.,2021.
APA	Qi S.(2021).Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas.J. Med. Chem..
MLA	Qi S."Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas".J. Med. Chem. (2021).